FDA Approves CardiAMPĀ® Heart Failure II Protocol Amendment to Use[...]
Analog Devices Reports Fiscal Third Quarter 2024 Financial Results Form 8 K
Axsome Therapeutics Reaches Agreement to Dismiss SunosiĀ® (Solriamfetol)[...]
21/08/2024 | Press release | Distributed by Public on 21/08/2024 17:41
Please select the service you want to use:
Smartlinks | Thakral Corporation Ltd. | News | Finance | Security Markets | Fixed Income | Bonds | Security Markets | Company News | Top Company News | Corporate Debt | Corporate Bonds | Consumer Electronics | Manufacturing | Professional and Business Services | Wholesale and Distribution | Securities Issuers | Wholesale Companies | Frankfurt Stock Exchange | Singapore Exchange (SGX) | Berlin Stock Exchange | Munich Stock Exchange
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact